Quality program for high-risk COPD, tested with primary care teams
Part of Lungs & breathing clinical trials.
This study looks at how well a quality-improvement program (called CONQUEST) helps people with higher-risk chronic lung disease (COPD) when delivered through primary care teams. It compares the program given right away versus usual care for a while, then the program later.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a primary care team (not an individual patient) that will be assigned to an approach.
- Your team can be randomly assigned as one group without too much “mixing” between team members or clinicians.
- Your practice has enough COPD patients who meet “modifiable high-risk” criteria to make results reliable.
- Your team agrees to be randomly assigned to either start CONQUEST right away or use usual care first, then get CONQUEST later.
- Your team cannot be in the middle of, or planning, changes to electronic health record (EHR) software or practice ownership during the study period.
- Your team cannot already be running a COPD quality-improvement project (or active research) that would make it hard to run CONQUEST.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a structured care program for COPD can lower how often your symptoms flare up. It may help by improving everyday management and preventing future worsening.
This trial studies cardiovascular (heart and blood vessel) risk in people who have stable COPD or a recent worsening of COPD. It may help researchers understand which risks to monitor during and after a COPD flare and how to prevent complications.
This trial studies a detailed, whole-body program to improve outcomes in people with COPD or heart failure, especially those who also have several other chronic conditions. It may help by improving activity and monitoring health markers over about 24 weeks.
This trial tests a short, intensive exercise program (pulmonary rehab) before lung cancer surgery. It also helps people quit smoking during the program. The goal is to see if this approach improves recovery after surgery.
This trial tests an inhaled medication called TQC3721 for people with moderate-to-severe chronic obstructive pulmonary disease (COPD). It aims to see if the drug can improve lung function and symptoms. For some participants, the trial is available to those who have not been in a previous TQC3721 study.
This study tests a virtual program called 'My Lung Health Coach' that helps people with COPD manage their condition through an app connected to their health record. The goal is to see if this self-management program can improve your breathing, reduce flare-ups, and help you feel more in control of your health.
Hear when a new Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.